USRTX
Price
$33.41
Change
+$0.24 (+0.72%)
Updated
Sep 4 closing price
Net Assets
689.44M
VSMPX
Price
$292.42
Change
+$2.56 (+0.88%)
Updated
Sep 4 closing price
Net Assets
1.95T
Interact to see
Advertisement

USRTX vs VSMPX

Header iconUSRTX vs VSMPX Comparison
Open Charts USRTX vs VSMPXBanner chart's image
Horizon Multi-Factor U.S. Equity Advisor
Price$33.41
Change+$0.24 (+0.72%)
VolumeN/A
Net Assets689.44M
Vanguard Total Stock Mkt Idx Instl Pls
Price$292.42
Change+$2.56 (+0.88%)
VolumeN/A
Net Assets1.95T
USRTX vs VSMPX Comparison Chart in %
Loading...
View a ticker or compare two or three
Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSMPX has more cash in the bank: 1.95T vs. USRTX (689M). VSMPX pays higher dividends than USRTX: VSMPX (1.17) vs USRTX (0.15). USRTX was incepted earlier than VSMPX: USRTX (6 years) vs VSMPX (10 years). USRTX (1.19) is less costly to investors than VSMPX (0.02). USRTX is a more actively managed with annual turnover of: 164.00 vs. VSMPX (2.00). USRTX has a lower initial minimum investment than VSMPX: USRTX (2500) vs VSMPX (100000000). VSMPX annual gain was more profitable for investors over the last year : 18.05 vs. USRTX (4.54). VSMPX return over 5 years is better than : 85.03 vs. USRTX (30.80).
USRTXVSMPXUSRTX / VSMPX
Total Expense Ratio1.190.025,950%
Annual Report Gross Expense Ratio1.190.025,950%
Fund Existence6 years10 years-
Gain YTD10.27110.35899%
Front LoadN/AN/A-
Min. Initial Investment25001000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets689M1.95T0%
Annual Yield % from dividends0.151.1713%
Returns for 1 year4.5418.0525%
Returns for 3 years38.5163.7160%
Returns for 5 years30.8085.0336%
Returns for 10 yearsN/A214.57-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OSTX2.200.11
+5.26%
OS Therapies Inc
EXAS53.812.40
+4.67%
Exact Sciences Corp
CMPO18.50-0.06
-0.32%
CompoSecure
TCI46.91-0.24
-0.51%
Transcontinental Realty Investors
SCNI1.50-0.06
-3.85%
Scinai Immunotherapeutics Ltd.